Works matching DE "23 %26 Me Inc."
1
- Journal of Popular Culture (John Wiley & Sons, Inc.), 2020, v. 53, n. 1, p. 58, doi. 10.1111/jpcu.12880
- Article
2
- Biochemistry & Molecular Biology Education, 2012, v. 40, n. 1, p. 63, doi. 10.1002/bmb.20583
- Article
3
- Marketing Health Services, 2014, v. 34, n. 2, p. 3
- Article
4
- Philosophy & Public Policy Quarterly, 2013, v. 31, n. 3/4, p. 27
- Article
5
- Screen, 2021, v. 62, n. 2, p. 217, doi. 10.1093/screen/hjab026
- Article
6
- Nature, 2012, v. 488, n. 7410, p. 134, doi. 10.1038/488134a
- Article
7
- Nature, 2012, v. 486, n. 7403, p. 312, doi. 10.1038/486312a
- Article
8
- Nature, 2012, v. 486, n. 7401, p. 10, doi. 10.1038/486010a
- Article
9
- Nature, 2011, v. 476, n. 7358, p. 10, doi. 10.1038/476010a
- Article
10
- Nature, 2009, v. 461, n. 7265, p. 724, doi. 10.1038/461724a
- Ng, Pauline C.;
- Murray, Sarah S.;
- Levy, Samuel;
- Venter, J. Craig
- Article
11
- Indiana Journal of Global Legal Studies, 2021, v. 28, n. 2, p. 293, doi. 10.2979/indjglolegstu.28.2.0293
- Article
12
- Medical Anthropology Quarterly, 2013, v. 27, n. 4, p. 573, doi. 10.1111/maq.12062
- Article
13
- Biologist, 2008, v. 55, n. 4, p. 230
- Article
14
- American Journal of Bioethics, 2009, v. 9, n. 6/7, p. 48, doi. 10.1080/15265160902918770
- Article
15
- Australian Medical Student Journal, 2012, v. 3, n. 2, p. 68
- Article
16
- UBC Medical Journal, 2013, v. 4, n. 2, p. 33
- Article
17
- New Humanist, 2020, v. 135, n. 2, p. 34
- Article
19
- Clinical Pharmacology & Therapeutics, 2014, v. 95, n. 6, p. 598, doi. 10.1038/clpt.2014.60
- Brownstein, C A;
- Margulies, D M;
- Manzi, S F
- Article
20
- Bio-IT World, 2008, v. 7, n. 9, p. 16
- Article
21
- Bio-IT World, 2008, v. 7, n. 5, p. 10
- Article
25
- Nature, 2015, v. 520, n. 7549, p. 597, doi. 10.1038/520597a
- Article
26
- Journal of Law, Information & Science, 2012, v. 22, n. 1, p. 132
- Article
28
- Revista de Derecho Puertorriqueño, 2022, v. 61, n. 2, p. 233
- Article
29
- Brooklyn Law Review, 2019, v. 85, n. 1, p. 185
- Article
30
- Applied Clinical Trials, 2013, v. 22, n. 10, p. 24
- Article
31
- New Genetics & Society, 2017, v. 36, n. 3, p. 250, doi. 10.1080/14636778.2017.1352469
- Article
32
- New Genetics & Society, 2017, v. 36, n. 3, p. 296, doi. 10.1080/14636778.2017.1354691
- Article
33
- New Genetics & Society, 2017, v. 36, n. 3, p. 209, doi. 10.1080/14636778.2017.1354690
- Article
34
- Nature Biotechnology, 2015, v. 33, n. 5, p. 435, doi. 10.1038/nbt0515-435a
- Article
35
- Nature Biotechnology, 2015, v. 33, n. 2, p. 119, doi. 10.1038/nbt0215-119a
- Article
36
- Nature Biotechnology, 2014, v. 32, n. 10, p. 967, doi. 10.1038/nbt1014-967
- Article
37
- Nature Biotechnology, 2014, v. 32, n. 1, p. 8, doi. 10.1038/nbt0114-8
- Article
38
- Nature Biotechnology, 2013, v. 31, n. 12, p. 1075, doi. 10.1038/nbt.2771
- Article
39
- Nature Biotechnology, 2013, v. 31, n. 1, p. 16, doi. 10.1038/nbt.2469
- Vayena, Effy;
- Prainsack, Barbara
- Article
40
- 2016
- Stoeklé, Henri-Corto;
- Mamzer-Bruneel, Marie-France;
- Vogt, Guillaume;
- Hervé, Christian
- journal article
41
- Health Matrix: Journal of Law-Medicine, 2017, v. 27, p. 143
- Article
42
- GeneWatch, 2015, v. 28, n. 3, p. 2
- Article
44
- Mississippi College Law Review, 2021, v. 39, n. 1, p. 80
- Article
45
- Nature, 2008, v. 453, n. 7194, p. 441, doi. 10.1038/453441a
- Article
46
- Nature, 2007, v. 450, n. 7166, p. 1, doi. 10.1038/450011a
- Article
47
- Journal of Case Studies, 2018, v. 36, n. 1, p. 78
- Whaley, George;
- McGuire, Stephen
- Article